Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

<p>Abstract</p> <p>Objectives</p> <p>To assess the efficacy and safety of a treatment switch from a twice-daily (BID) regimen containing zidovudine (ZDV) and lamivudine (3TC) plus a third agent to a once daily (QD) regimen containing the fixed-dose combination of tenofo...

Full description

Bibliographic Details
Main Authors: Arasteh K, Weitner L, Fenske S, Kuhlmann B, Freiwald M, Ebrahimi R, Gallo L, Ranneberg B, Mertenskoetter T
Format: Article
Published: BMC 2009-05-01
Series:European Journal of Medical Research
Online Access:http://www.eurjmedres.com/content/14/5/195